346 related articles for article (PubMed ID: 34340592)
1. Do Ultrasound Patterns and Clinical Parameters Inform the Probability of Thyroid Cancer Predicted by Molecular Testing in Nodules with Indeterminate Cytology?
Figge JJ; Gooding WE; Steward DL; Yip L; Sippel RS; Yang SP; Scheri RP; Sipos JA; Mandel SJ; Mayson SE; Burman KD; Folek JM; Haugen BR; Sosa JA; Parameswaran R; Tan WB; Nikiforov YE; Carty SE
Thyroid; 2021 Nov; 31(11):1673-1682. PubMed ID: 34340592
[No Abstract] [Full Text] [Related]
2. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
[TBL] [Abstract][Full Text] [Related]
3. Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.
Modi L; Sun W; Shafizadeh N; Negron R; Yee-Chang M; Zhou F; Simsir A; Sheth S; Brandler TC
Cancer Cytopathol; 2020 Jul; 128(7):470-481. PubMed ID: 32078249
[TBL] [Abstract][Full Text] [Related]
4. Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.
Steward DL; Carty SE; Sippel RS; Yang SP; Sosa JA; Sipos JA; Figge JJ; Mandel S; Haugen BR; Burman KD; Baloch ZW; Lloyd RV; Seethala RR; Gooding WE; Chiosea SI; Gomes-Lima C; Ferris RL; Folek JM; Khawaja RA; Kundra P; Loh KS; Marshall CB; Mayson S; McCoy KL; Nga ME; Ngiam KY; Nikiforova MN; Poehls JL; Ringel MD; Yang H; Yip L; Nikiforov YE
JAMA Oncol; 2019 Feb; 5(2):204-212. PubMed ID: 30419129
[TBL] [Abstract][Full Text] [Related]
5. Repeat Fine Needle Aspiration Cytology Refines the Selection of Thyroid Nodules for Afirma Gene Expression Classifier Testing.
Nishino M; Mateo R; Kilim H; Feldman A; Elliott A; Shen C; Hasselgren PO; Wang H; Hartzband P; Hennessey JV
Thyroid; 2021 Aug; 31(8):1253-1263. PubMed ID: 33813868
[No Abstract] [Full Text] [Related]
6. Performance of a Multigene Genomic Classifier in Thyroid Nodules with Suspicious for Malignancy Cytology.
Skaugen JM; Taneja C; Liu JB; Wald AI; Nikitski AV; Chiosea SI; Seethala RR; Ohori NP; Karslioglu-French E; Carty SE; Nikiforova MN; Yip L; Nikiforov YE
Thyroid; 2022 Dec; 32(12):1500-1508. PubMed ID: 35864811
[No Abstract] [Full Text] [Related]
7. UTILITY OF AFIRMA GENE EXPRESSION CLASSIFIER FOR EVALUATION OF INDETERMINATE THYROID NODULES AND CORRELATION WITH ULTRASOUND RISK ASSESSMENT: SINGLE INSTITUTIONAL EXPERIENCE.
Sultan R; Levy S; Sulanc E; Honasoge M; Rao SD
Endocr Pract; 2020 May; 26(5):543-551. PubMed ID: 31968199
[No Abstract] [Full Text] [Related]
8. Can cytology and the Thyroid Imaging, Reporting, and Data System (TI-RADS) identify noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) before surgery?
Yang GCH; Fried KO; Scognamiglio T
J Am Soc Cytopathol; 2020; 9(3):159-165. PubMed ID: 32111537
[TBL] [Abstract][Full Text] [Related]
9. Ultrasonography Classification of the American Thyroid Association for Predicting Malignancy in Thyroid Nodules >1cm with Indeterminate Cytology: A Prospective Study.
Rocha TG; Rosario PW; Silva AL; Nunes MB; Silva TH; de Oliveira PHL; Calsolari MR
Horm Metab Res; 2018 Aug; 50(8):597-601. PubMed ID: 30081407
[TBL] [Abstract][Full Text] [Related]
10. USING THE ATA AND ACR TI-RADS SONOGRAPHIC CLASSIFICATIONS AS ADJUNCTIVE PREDICTORS OF MALIGNANCY FOR INDETERMINATE THYROID NODULES.
Ahmadi S; Herbst R; Oyekunle T; Jiang X'; Strickland K; Roman S; Sosa JA
Endocr Pract; 2019 Sep; 25(9):908-917. PubMed ID: 31170369
[No Abstract] [Full Text] [Related]
11. Performance of a multigene genomic classifier and clinical parameters in predicting malignancy in a Southeast Asian cohort of patients with cytologically indeterminate thyroid nodules.
Yang SP; Nga ME; Bundele MM; Chiosea SI; Tan SH; Lum JHY; Parameswaran R; Lim MY; Li H; Cheah WK; Sek KS; Tan ATH; Loh TKS; Ngiam KY; Tan WB; Huang X; Ho TWT; Lim KH; Lim CM; Singaporewalla RM; Rao AD; Rao NCL; Chua DYK; Chin DC; Wald AI; LiVolsi VA; Nikiforov YE; Tai ES
Cancer Cytopathol; 2024 May; 132(5):309-319. PubMed ID: 38319805
[TBL] [Abstract][Full Text] [Related]
12. Risk Stratification in Patients With Follicular Neoplasm on Cytology: Use of Quantitative Characteristics and Sonographic Patterns.
Wu MH; Chen KY; Hsieh MS; Chen A; Chen CN
Front Endocrinol (Lausanne); 2021; 12():614630. PubMed ID: 33995270
[TBL] [Abstract][Full Text] [Related]
13. A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology-A Pilot Cohort Study.
Gomes-Lima CJ; Auh S; Thakur S; Zemskova M; Cochran C; Merkel R; Filie AC; Raffeld M; Patel SB; Xi L; Wartofsky L; Burman KD; Klubo-Gwiezdzinska J
Front Endocrinol (Lausanne); 2020; 11():53. PubMed ID: 32132976
[No Abstract] [Full Text] [Related]
14. Evaluation of ACR TI-RADS cytologically indeterminate thyroid nodules and molecular profiles: a single-institutional experience.
Belovarac B; Zhou F; Modi L; Sun W; Shafizadeh N; Negron R; Yee-Chang M; Szeto O; Simsir A; Sheth S; Brandler TC
J Am Soc Cytopathol; 2022; 11(3):165-172. PubMed ID: 35181254
[TBL] [Abstract][Full Text] [Related]
15. Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.
Strickland KC; Howitt BE; Barletta JA; Cibas ES; Krane JF
Cancer Cytopathol; 2018 Feb; 126(2):86-93. PubMed ID: 28914983
[TBL] [Abstract][Full Text] [Related]
16. Thyroid Ultrasound-Guided Fine-Needle Aspiration Cytology Results: Observed Increase in Indeterminate Rate over the Past Decade.
Manning AM; Yang H; Falciglia M; Mark JR; Steward DL
Otolaryngol Head Neck Surg; 2017 Apr; 156(4):611-615. PubMed ID: 28118554
[TBL] [Abstract][Full Text] [Related]
17. The Effect Modification of Ultrasound Risk Classification on Molecular Testing in Predicting the Risk of Malignancy in Cytologically Indeterminate Thyroid Nodules.
Hu TX; Nguyen DT; Patel M; Beckett K; Douek M; Masamed R; Rhyu J; Kim J; Tseng CH; Yeh MW; Livhits MJ
Thyroid; 2022 Aug; 32(8):905-916. PubMed ID: 35611970
[No Abstract] [Full Text] [Related]
18. Molecular testing for indeterminate thyroid nodules: Performance of the Afirma gene expression classifier and ThyroSeq panel.
Jug RC; Datto MB; Jiang XS
Cancer Cytopathol; 2018 Jul; 126(7):471-480. PubMed ID: 29637728
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of cancer and the benign call rate of afirma gene classifier in
Endo M; Sipos JA; Ringel MD; Porter K; Nagaraja HN; Phay JE; Shirley LA; Long C; Wright CL; Roll K; Nabhan FA
Cancer Med; 2021 Feb; 10(3):1084-1090. PubMed ID: 33449450
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonography scoring systems can rule out malignancy in cytologically indeterminate thyroid nodules.
Grani G; Lamartina L; Ascoli V; Bosco D; Nardi F; D'Ambrosio F; Rubini A; Giacomelli L; Biffoni M; Filetti S; Durante C; Cantisani V
Endocrine; 2017 Aug; 57(2):256-261. PubMed ID: 27804016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
